Matinas BioPharma faces NYSE notice over equity shortfall; gets until 2027 to comply
Seeking Alpha ·
Matinas BioPharma ( MTNB ) announced on Friday that it received a notice from NYSE American for not meeting the exchange's minimum shareholder equity requirement. The company's shareholder equity fell to $3.02M in March 2026, below the required $4M threshold after posting losses for the
DYAX Investor Sentiment
Bullish (Long) 70% · Bearish (Short) 30%
384 participants
Related News
- Where Will XRP Be in 3 Years?
- Uber (UBER) Shares Skyrocket, What You Need To Know
- What If The Real Power Behind Marvell Stock Isn't Just Growth?
- Adobe (ADBE) Buys Topaz Labs As It Expands Agentic AI Partnerships
- Amazon (AMZN) Commits $13 Billion To India As AWS Faces EU Gatekeeper Status
- AbbVie's Skyrizi gains pediatric psoriatic disease indication